Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing innovative cell and gene therapies for life-threatening genetic diseases. Its lead product, pz-cel, targets recessive dystrophic epidermolysis bullosa (RDEB) and has shown promising clinical results. With a strong emphasis on advanced manufacturing capabilities and strategic partnerships, Abeona aims to address significant unmet medical needs in rare diseases, leveraging its proprietary AIM™ capsid technology for future therapies.
This description was generated via AI from an annual report. Updated about 1 year ago.